About EMulate

About Emulate Therapeuthics

Who EMulate Therapeutics is

A science company built around one idea: cells can be guided with information, not just chemicals.

EMulate Therapeutics is a clinical-stage health technology company focused on ultra low radio frequency energy (ulRFE®), a platform that encodes the behavioral “signature” of molecules into safe electromagnetic signals. These signals are delivered through a wearable device that is designed to influence specific biological pathways involved in disease and recovery.

The company's work centers on three goals: expanding what is possible in treating serious disease, reducing the burden of toxicity and side effects, and making advanced therapeutics more accessible and patient friendly.

Focus

Digital Therapeutics

Core Technology

ulRFE® platform

Therapeutic Areas

Oncology, mental health, pain management

Delivery

Non-invasive wearable device

Mission, Vision and Purpose

Mission

To develop and deliver safe, non-invasive digital therapeutics that improve outcomes for patients with cancer, neurological disorders, and chronic conditions.

Vision

A world where many of the most serious diseases can be managed or treated through precisely targeted, information-based therapies that work with the body instead of against it.

Purpose

EMulate exists to translate complex biophysics into practical medical tools that are easy to use, clinically sound, and aligned with how people actually live.

Our Journey so far

History and Milestones

2018

Early Research and Discovery

Foundational work in biophysics and electromagnetic signaling leads to the initial concept of ultra low radio frequency energy (ulRFE®).

2018

First Preclinical Evidence

Laboratory studies indicate that specific signal patterns can influence cellular behavior and relevant biological pathways.

2018

Initial Human Experiences

Early clinical use in oncology and other conditions informs device design, safety considerations, and signal protocols.

2018

Platform and Device Refinement

Iterative improvements in hardware, software, and signal encoding increase precision, consistency, and usability.

2018

Clinical Programs and Partnerships

EMulate initiates and supports clinical and observational studies while building collaborations with investigators and industry partners.

Leadership and Advisors

EMulate's leadership team brings together experience in biophysics, signal processing, oncology, neurology, medical device development, and clinical trial operations. The company is also supported by medical, scientific, and business advisors from leading institutions and companies.

Values and Culture

How EMulate chooses to work:

Evidence first
Patients at the center
Transparency
Collaboration
Responsibility

Looking Ahead

EMulate Therapeutics is still early in a long journey. The company is focused on generating robust clinical evidence, refining its platform, and building collaborations that can move ulRFE® from promising science to widely available care.

EMulate is working toward a future where many complex diseases can be treated with precision-guided signals, not just stronger drugs.

Contact emulate therapeutics Explore our technology